Skip to main content
logo
Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
34.08
-0.10 (-0.29%)
At close: Sep 10, 2026, 4:00 PM EDT
34.07
-0.02 (-0.04%)
After-hours: Sep 10, 2026, 7:30 PM EDT

Cogent Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
98.3763.5843.2834.3826.2119.64
Research & Development
290.72269.78232.66173.76121.6355.91
Operating Expenses
389.09333.36275.94208.13147.8475.55
Operating Income
-389.09-333.36-275.94-208.13-147.84-75.55
Interest Expense
-5.18-3.06----
Interest & Investment Income
24.4314.6918.0913.083.990.47
Other Non Operating Income (Expenses)
-0.16-0.021.992.643.612.81
EBT Excluding Unusual Items
-370-321.76-255.86-192.41-140.24-72.27
Other Unusual Items
-7.18-7.18----
Pretax Income
-377.18-328.94-255.86-192.41-140.24-72.27
Earnings From Continuing Operations
--328.94-255.86-192.41-140.24-72.27
Net Income
-377.18-328.94-255.86-192.41-140.24-72.27
Net Income to Common
-377.18-328.94-255.86-192.41-140.24-72.27
Net Income Growth
------
Shares Outstanding (Basic)
155129104805939
Shares Outstanding (Diluted)
155129104805939
Shares Change
37.58%24.09%30.48%35.41%51.89%249.52%
EPS (Basic)
-2.43-2.55-2.46-2.42-2.38-1.87
EPS (Diluted)
-2.43-2.55-2.46-2.42-2.38-1.87
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-309.24-266-208.36-156.42-125.5-60.48
Free Cash Flow Per Share
-2.00-2.06-2.00-1.96-2.13-1.56
EBITDA
-386.46-330.8-273.49-205.86-147-75.4
D&A For EBITDA
2.642.562.452.270.840.15
EBIT
-389.09-333.36-275.94-208.13-147.84-75.55
SEC Filings: 10-K · 10-Q